Abiopharma

Clinical trial NCT04614194: primary completion date: 2026-04-15 → 2027-04-15.

Clinical trial NCT06052631: start date: 2026-06-21 → 2026-06-22.

Clinical trial NCT05556096: enrollment: 261 → 260 participants.

Clinical trial NCT03556332 updates: 1. completion date: 2026-07-01 → 2027-07-01 2. primary completion date: 2026-07-01 → 2027-07-01

Clinical trial NCT05742607 updates: 1. completion date: 2026-09-01 → 2027-06-01 2. primary completion date: 2025-06-01 → 2027-06-01

Clinical trial NCT05551793 updates: 1. completion date: 2027-11-03 → 2028-10-31 2. primary completion date: 2027-11-03 → 2027-11-30 3. enrollment: 68 → 76 participants

Clinical trial NCT07029711 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-05-18 → 2027-01-06 3. primary completion date: 2027-04-20 → 2026-12-02 4. enrollment: 225 → 208 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07340190: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT06300450 updates: 1. completion date: 2026-07-30 → 2026-12-30 2. primary completion date: 2026-02-28 → 2026-12-28

Clinical trial NCT05838482 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-04-30 3. primary completion date: 2026-06-01 → 2026-04-30 4. enrollment: 100 → 45 participants 5. enrollment type: ESTIMATED → ACTUAL